Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes well beyond the annotations: it discloses the fan-out across SEC EDGAR, XBRL, USPTO, USAspending, FDA Purple Book, DOL LCA, news, and GLEIF; explains that empty sections are real 'no data'; notes that the patents source soft-fails; and clarifies that private companies return resolved:false with explicit notes. Annotations already indicate readOnly/idempotent behavior, and the description reinforces rather than contradicts them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but the length is largely earned because there is no output schema and the tool aggregates many sources. It front-loads the core purpose and trigger phrases before diving into source and field details. A little trimming or structuring with headings would improve scannability, but each sentence contributes real information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return values, and it does so thoroughly: it enumerates resolved identity, recent filings, fundamentals, patents, federal contracts, FDA products, hiring, news, LEI, and sources_used/sources_failed. It also handles edge cases like private companies, name resolution, CIK padding, and expected empty sections, making the tool highly callable as documented.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the baseline is 3; both `type` and `value` are already well documented in the schema, including the fact that company/ticker are interchangeable and that ticker, CIK, or company name are accepted. The description adds helpful examples and output-related resolution details, but it does not substantially add new meaning about the parameters themselves.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb-resource pairing: it produces 'full cross-source profile of a US public company in ONE parallel call' and is aimed at holistic lookups like 'Tell me about X' or 'brief me on Tesla.' It distinguishes itself from chained single-source SEC/XBRL/news lookups, and the trigger phrases make the intended use obvious.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' which gives clear when-to-use guidance and names the general alternative. It does not, however, discuss when a different holistic sibling like deep_research or compare_entities might be more appropriate, so it stops short of full exclusion logic.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tool clusters overlap heavily — ask_pipeworx_beta is functionally identical to ask_pipeworx right now, and the six Polymarket tools (polymarket_edges, polymarket_arbitrage, bet_research, etc.) have blurry boundaries. The entity-research family (entity_profar, compare_entities, recent_changes) is also easy to misselect despite detailed descriptions.

Naming Consistency3/5

All names are snake_case, but conventions are mixed: verb_noun (resolve_entaty, validate_claim), bare verbs (remember, recall, query), adjective_noun (recent_alerts, recent_changes), and brand-prefixed nouns (polymarket_edges, pipeworx_trending). Family prefixes and verbs help readability, but the overall pattern is not uniform.

Tool Count2/5

At 34 tools this exceeds the 25+ threshold and spans loosely related domains — Bloomington open data, Pipeworx research, prediction markets, AI marketing, memory, npm scanning, and llms.txt generation. The scope feels heavy and unfocused relative to the 'Data Bloomington' server name.

Completeness4/5

The core research lifecycle is well covered: routing (ask_pipeworx), grounded verification, deep research, entity profiles/comparisons/changes, claim validation, entity resolution, subscriptions, and memory all exist. Minor gaps remain — no standalone tool for fetching a pipeworx:// citation URI and no API-key management — but agents can work around them.